{
  "meta": {
    "timestamp": "2025-01-06T13:55:47.036169",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Quantum-Si Inc",
      "symbol": "QSI",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "High competition in the biotechnology and proteomics sector",
            "Slow adoption of new protein sequencing technologies",
            "Financial underperformance and lack of profitability",
            "Regulatory scrutiny and compliance risks",
            "Overvaluation concerns and stock volatility"
          ],
          "controversies": [
            "Mixed analyst ratings and downgrades",
            "Recent decline in stock price by 18.92% in a single trading session",
            "Regaining compliance with Nasdaq\u2019s minimum bid price requirement"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Potential to advance personalized medicine and drug discovery",
            "Challenges in integrating new technologies into existing healthcare workflows"
          ],
          "governance_issues": [
            "Regulatory compliance and potential impact on commercialization timelines"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Annual Reports - Quantum-Si Incorporated",
              "snippet": "The Investor Relations website contains information about Quantum-Si Incorporated's business for stockholders, potential investors, and financial analysts.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:21.735705+00:00",
              "published_date": null,
              "source_hash": "822b51234ccad4e1c5ed1fbe6843ee0d"
            },
            {
              "url": "",
              "title": "QSI | Quantum-Si Inc. Financial Statements - WSJ",
              "snippet": "Quantum-Si Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View QSI financial statements in full.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:15.798781+00:00",
              "published_date": null,
              "source_hash": "089c3a66172fdf31569ab73998934052"
            },
            {
              "url": "",
              "title": "Quantum-Si Inc (QSI) Reports Revenue Growth and Reduced Net Loss in ...",
              "snippet": "On February 29, 2024, Quantum-Si Inc ... Financial Performance and Challenges. ... generating $400,000 in revenue with a gross profit of $178,000. The full year saw the company earn $1.1 million ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:15.798794+00:00",
              "published_date": null,
              "source_hash": "a673d27d4dd41064a9a95db19dff1ad3"
            },
            {
              "url": "",
              "title": "Quantum-Si Reports First Quarter 2024 Financial Results",
              "snippet": "Executed Full Commercial Launch of Platinum\u00ae Instrument Reaffirms Full Year 2024 Financial Guidance BRANFORD, Conn.-(BUSINESS WIRE)-May 9, 2024- Quantum-Si Incorporated (Nasdaq: QSI) (\"Quantum-Si,\" \"QSI\" or the \"Company\"), The Protein Sequencing Company\u2122, today announced financial results for the first quarter ended March 31, 2024. Press Release Highlights Reported revenue ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:15.798805+00:00",
              "published_date": null,
              "source_hash": "c3ab21668bd0027b04f938305e85ea7f"
            },
            {
              "url": "",
              "title": "Quantumsi Inc (QSI) 10K Annual Reports & 10Q SEC Filings",
              "snippet": "Gross profit was $178,000 and gross margin was 45%. For the full year ended December 31, 2023, the Company recorded revenue of $1.1 million, gross profit of $488,000, and gross margin of 45%. ... Quantum-Si will host a conference call to discuss its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, at 4:30 p.m ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:15.798821+00:00",
              "published_date": null,
              "source_hash": "f0f288cf26976f6f2a6ac9c8ad5293dd"
            },
            {
              "url": "",
              "title": "QSI | Quantum-Si Inc. Annual Income Statement | MarketWatch",
              "snippet": "Quantum-Si Inc. Annual stock financials by MarketWatch. View the latest QSI financial statements, income statements and financial ratios. ... Gross Profit Margin. Gross Profit Margin----339.00%.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:15.798833+00:00",
              "published_date": null,
              "source_hash": "c574dadd71c5167df5c673298b1ee963"
            },
            {
              "url": "",
              "title": "Quantum-Si incorporated (QSI) Income Statement - Yahoo Finance",
              "snippet": "Get the detailed quarterly/annual income statement for Quantum-Si incorporated (QSI). Find out the revenue, expenses and profit or loss over the last fiscal year.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:15.798844+00:00",
              "published_date": null,
              "source_hash": "ed259714952bf47461d3ddd8f0ca968c"
            },
            {
              "url": "",
              "title": "Quantum-Si incorporated (QSI) Valuation Measures & Financial Statistics",
              "snippet": "Find out all the key statistics for Quantum-Si incorporated (QSI), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Profit Margin : 0. ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:15.798853+00:00",
              "published_date": null,
              "source_hash": "97e94fc6d8dc8e67f3b217a6167c6712"
            },
            {
              "url": "",
              "title": "Quantum-Si Financial Statements 2019-2024 | QSI - Macrotrends",
              "snippet": "Ten years of annual and quarterly financial statements and annual report data for Quantum-Si (QSI). Income statements, balance sheets, cash flow statements and key ratios.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:15.798861+00:00",
              "published_date": null,
              "source_hash": "a2661ca3507ba29bc8c76191da7181ea"
            },
            {
              "url": "",
              "title": "Quantum-Si incorporated Income Statement - Stock Analysis",
              "snippet": "Detailed annual and quarterly income statement for Quantum-Si incorporated (QSI). See many years of revenue, expenses and profits or losses.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:15.798871+00:00",
              "published_date": null,
              "source_hash": "5bcf9ce7e23b7844ecf3f1836c0ba14c"
            },
            {
              "url": "",
              "title": "Quantum-Si Inc (QSI) Stock Rated Buy by H.C. Wainwright",
              "snippet": "H.C. Wainwright has recently initiated Quantum-Si Inc (QSI) stock to Buy rating, as announced on December 8, 2023, according to Finviz. Earlier, on September 25, 2023, Canaccord Genuity had reduced the stock from a Buy to Hold,",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:30.363865+00:00",
              "published_date": "2025-01-06T18:44:00+00:00",
              "source_hash": "c3ccfddcbdfdbd50fd71a8b7b409e0a7"
            },
            {
              "url": "",
              "title": "Quantum-Si Inc (QSI) Stock Sees Market Value Hit $385.32 million: What Are the Implications?",
              "snippet": "On Tuesday, Quantum-Si Inc (QSI) stock saw a decline, ending the day at $2.7 which represents a decrease of $-0.63 or -18.92% from the prior close of $3.33. The stock opened at $3.2 and touched a low of $2.64 during the day, reaching a high of $3.63. The volume of shares traded was 43.01 million exceeding the average volume of 18.00 million.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:30.363903+00:00",
              "published_date": "2025-01-02T14:43:00+00:00",
              "source_hash": "a6976af5a9d55e6d0f1be380ae618e0c"
            },
            {
              "url": "",
              "title": "Quantum-Si Isn't A Quantum Computing Company, And Shares Are Overvalued",
              "snippet": "Quantum-Si has badly missed its initial SPAC projections and is struggling to gain commercial momentum. Read why QSI stock is a Sell.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:18.355134+00:00",
              "published_date": "2024-12-29T06:00:00+00:00",
              "source_hash": "bcffdb33789cd1d9336a7ea3f613be0b"
            },
            {
              "url": "",
              "title": "Quantum-Si: Another Wrong Horse On The Quantum Computing Racetrack - Sell",
              "snippet": "Quantum-Si is a life sciences company not involved in quantum computing, with a Sell rating. Explore more here on QSI stock.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:30.363915+00:00",
              "published_date": "2025-01-04T04:45:00+00:00",
              "source_hash": "64851dcc34ac85bae44140c0bf928089"
            },
            {
              "url": "",
              "title": "Quantum-Si Incorporated - Ordinary Shares - Class A",
              "snippet": "Quantum-Si, Inc. engages in the development of a proprietary ... industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc financial performance and profitability concerns",
              "retrieved_at": "2025-01-06T20:55:18.355154+00:00",
              "published_date": "2021-06-14T10:18:00+00:00",
              "source_hash": "979b8a79d6741aa5c4ca67ed75a26d72"
            },
            {
              "url": "",
              "title": "Quantum-Si Clarifies Status of Financial Disclosure",
              "snippet": "Quantum-Si has released an update to notify the public and investors about a regulation fd disclosure.Quantum-Si Incorporated recently announced in a press release that their latest financial ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:21.735638+00:00",
              "published_date": null,
              "source_hash": "4c5143b9b79f0dfd2f13a7769f44824f"
            },
            {
              "url": "",
              "title": "Branford-based biotech Quantum-Si avoids Nasdaq delisting",
              "snippet": "It took less than a month for Branford-based biotech firm Quantum-Si Inc. to regain compliance for listing its stock on The Nasdaq Stock Market. In a filing with the Securities and Exchange ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:24.638443+00:00",
              "published_date": "2024-12-10T15:11:00+00:00",
              "source_hash": "5033c3aaeebb143adba9934310db489b"
            },
            {
              "url": "",
              "title": "Quantumsi Inc (QSI) 10K Annual Reports & 10Q SEC Filings",
              "snippet": "Quantum-Si will host a conference call to discuss its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, at 4:30 p.m. Eastern Time. ... the Company's ability to obtain and maintain regulatory approval for its products, and any related restrictions and limitations of any approved product; the Company's ability to ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:21.735715+00:00",
              "published_date": null,
              "source_hash": "1c230882d27cf00cd6432aec9c6c23ce"
            },
            {
              "url": "",
              "title": "QSI - Quantum-Si Stock SEC Filings - Barchart.com",
              "snippet": "SEC Filings for Quantum-Si Inc (QSI) including Annual 10-K and Quarterly 10-Q Reports.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:21.735724+00:00",
              "published_date": null,
              "source_hash": "6fc7639fffd2f5d9d26137957c6032ac"
            },
            {
              "url": "",
              "title": "QSI SEC Filings - Quantum-Si incorporated- Annual Report, Proxy ...",
              "snippet": "us74765k1051020323.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) Quantum-Si Inc - (Name of Issuer) Common Stock - (Title of Class of Securities) 74765K105 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:21.735732+00:00",
              "published_date": null,
              "source_hash": "f46b4fb80d05e084cd3ea0388d86cc41"
            },
            {
              "url": "",
              "title": "Quantum-Si Incorporated Announces Pricing of $50 Million Registered ...",
              "snippet": "BRANFORD, Conn.--(BUSINESS WIRE)--Jan. 3, 2025-- Quantum-Si Incorporated (Nasdaq: QSI) (\"Quantum-Si,\" \"QSI\" or the \"Company\"), The Protein Sequencing Company\u2122, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 15,625,000 shares of common stock at a purchase price of $3.20 per share, pursuant to a ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:21.735741+00:00",
              "published_date": null,
              "source_hash": "c731ef1da727c2637bd678c2013f8407"
            },
            {
              "url": "",
              "title": "QUANTUM-SI INC : Regulation FD Disclosure (form 8-K)",
              "snippet": "Item 7.01 Regulation FD Disclosure. Quantum-Si Incorporated (the \"Company\") is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022 at 4:30 pm Eastern Time.Presentation slides will be available on the \"Investors\" section of the Company's website at https://ir.quantum-si.com.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:21.735753+00:00",
              "published_date": null,
              "source_hash": "5c281470f86445929baf58c98febb1d4"
            },
            {
              "url": "",
              "title": "Quantum-Si incorporated (QSI) Company Profile & Overview - Stock Analysis",
              "snippet": "Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; Proteus, transforming proteomic research; and reagent kits and ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:21.735761+00:00",
              "published_date": null,
              "source_hash": "98f6c9b4cd8431848db07a9322c80c9c"
            },
            {
              "url": "",
              "title": "Quantum-Si Regains Compliance With Nasdaq Listing Requirements",
              "snippet": "NEW YORK - Protein sequencing firm Quantum-Si has regained compliance with Nasdaq listing requirements, according to a filing with the US Securities and Exchange Commission last week. As of Dec. 4, the company's stock had closed above $1.00 per share for 10 consecutive business days, bringing it back into compliance with the Nasdaq's minimum bid price requirement.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:21.735770+00:00",
              "published_date": null,
              "source_hash": "4061d21eb023f8a9295df49e804a84a4"
            },
            {
              "url": "",
              "title": "Quantum-Si Inc (NASDAQ:QSI) Regains Compliance with Nasdaq Minimum Bid Price Requirement",
              "snippet": "Investors and stakeholders are encouraged to remain informed about Quantum-Si's regulatory developments, particularly concerning bid price compliance and Nasdaq listing standards, as the company ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Quantum-Si Inc Quantum-Si Inc regulatory compliance and FDA approvals",
              "retrieved_at": "2025-01-06T20:55:24.638278+00:00",
              "published_date": "2024-12-10T00:00:00+00:00",
              "source_hash": "6846a9e18c401f82e977ef157965b10d"
            },
            {
              "url": "",
              "title": "Quantum-Si Incorporated: Business Model, SWOT Analysis, and Competitors ...",
              "snippet": "Quantum-Si's key strengths include its innovative technology, strong R&D capabilities, strategic partnerships, and an experienced management team. 5. What challenges does Quantum-Si face? Quantum-Si faces challenges such as high R&D costs, intense competition, and potential regulatory hurdles that could impact its growth trajectory. 6.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:27.982551+00:00",
              "published_date": null,
              "source_hash": "c83dec14b450523aed510f3cda92f18b"
            },
            {
              "url": "",
              "title": "Quantum-Si Incorporated (NASDAQ: QSI): A Competitive Analysis And ...",
              "snippet": "In today's recent session, 16.52 million shares of the Quantum-Si Incorporated (NASDAQ:QSI) have been traded, and its beta is 3.23. Most recently the company's share price was $1.79, and it changed around $0.46 or 34.96% from the last close, which brings the market valuation of the company to $283.92M.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:27.982660+00:00",
              "published_date": null,
              "source_hash": "950ad1e5bf52c0a4b5bf1aee08f146c3"
            },
            {
              "url": "",
              "title": "Quantum-Si: Hold Rating Affirmed Amidst Market ... - Markets Insider",
              "snippet": "The expansion of the sales team and distribution partnerships are strategic moves to improve market reach, but the analyst emphasizes the necessity for Quantum-Si to prove the utility of its ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:27.982675+00:00",
              "published_date": null,
              "source_hash": "5f163a6f91c24366472581eeb487cb00"
            },
            {
              "url": "",
              "title": "Quantum Si Incorporated Comparisons to its Competitors and Market Share ...",
              "snippet": "Quantum Si Incorporated's competitive profile, comparisons of quarterly results to its competitors, by sales, income, profitability, market share by products and services - CSIMarket",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:27.982685+00:00",
              "published_date": null,
              "source_hash": "796f3205a682da577b50acd7329a848a"
            },
            {
              "url": "",
              "title": "Quantum-Si (QSI) Competitors and Alternatives 2025 - MarketBeat",
              "snippet": "Transcat presently has a consensus target price of $130.25, indicating a potential upside of 22.80%. Quantum-Si has a consensus target price of $3.25, indicating a potential downside of 23.71%. Given Transcat's stronger consensus rating and higher probable upside, analysts plainly believe Transcat is more favorable than Quantum-Si.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:27.982695+00:00",
              "published_date": null,
              "source_hash": "266666840118fed6027548e44e1b9e93"
            },
            {
              "url": "",
              "title": "Quantum-Si Isn't A Quantum Computing Company, And Shares Are Overvalued",
              "snippet": "Rigetti Computing Inc. has surged 2,090%, while D-Wave Quantum Inc. is up 909%. IonQ is up 464%, its smaller gain likely a result of the fact that it started with a substantially larger market cap ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:27.982704+00:00",
              "published_date": null,
              "source_hash": "78ca130512fcc67a813f00bb964d69c4"
            },
            {
              "url": "",
              "title": "Quantum-Si: Lack Of Commercial Traction Despite Product Upgrades",
              "snippet": "The market responded positively, on Nov 19 th shares closed at $0.63 and hit a high of $1.88 one day later, a 200% increase in 24 hours. Despite some volatility, they have held on to most of these ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:27.982713+00:00",
              "published_date": null,
              "source_hash": "94c95e6001795dd0a211e2764e303bc6"
            },
            {
              "url": "",
              "title": "Quantum-Si (QSI) Stock Price, News & Analysis - MarketBeat",
              "snippet": "Quantum-Si has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings. Amount of Analyst Coverage. Quantum-Si has only been the subject of 2 research reports in the past 90 days. Read more about Quantum-Si's stock forecast and price target.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:27.982722+00:00",
              "published_date": null,
              "source_hash": "678f159b8597a6683a2c0bcca4f7a4ed"
            },
            {
              "url": "",
              "title": "Quantum-Si incorporated (QSI): A Bull Case Theory - Yahoo Finance",
              "snippet": "Quantum-Si incorporated (NASDAQ:QSI)'s share was trading at $2.70 as of Dec 31st. Quantum-Si (NASDAQ:QSI) is a pioneering life sciences company developing a groundbreaking single-molecule ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:27.982730+00:00",
              "published_date": null,
              "source_hash": "62c5f5923d36b8e6605d1fd288b14ff0"
            },
            {
              "url": "",
              "title": "Quantum Si Incorporated Market share relative to its competitors, as of ...",
              "snippet": "QSI's vs. Market share relative to its competitors, as of Q2 2024. As of Q2 2024 (Revenue in Millions of $) Date modified: 2024-10-07T03:27:14+00:00",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:27.982739+00:00",
              "published_date": null,
              "source_hash": "240bb7dec1874e0383a48be3c10818bd"
            },
            {
              "url": "",
              "title": "Quantum-Si Inc. Wt",
              "snippet": "Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:30.363924+00:00",
              "published_date": "2024-11-15T00:00:00+00:00",
              "source_hash": "fc22c0a4c11fd0d27235bf32e9624871"
            },
            {
              "url": "",
              "title": "Quantum-Si price target lowered to $1 from $1.50 at Canaccord",
              "snippet": "Canaccord added that the valuation upside will be \"limited\" until Quantum-Si drives higher levels of adoption over time. TipRanks is the most comprehensive data set of sell side analysts and ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Quantum-Si Inc Quantum-Si Inc market competition and adoption barriers",
              "retrieved_at": "2025-01-06T20:55:30.363932+00:00",
              "published_date": "2024-11-12T20:35:00+00:00",
              "source_hash": "a18d8a06493e73d5c03ad430ac3488f7"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Quantum-Si Inc financial performance and profitability concerns",
              "rationale": "Assess the company's financial stability and challenges in achieving profitability",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "Quantum-Si Inc regulatory compliance and FDA approvals",
              "rationale": "Investigate potential regulatory hurdles and compliance issues with clinical diagnostics",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Quantum-Si Inc market competition and adoption barriers",
              "rationale": "Explore challenges in differentiating technology and gaining market share in a competitive industry",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T13:55:47.036180",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}